Pro Medicus is a healthcare IT company specializing in radiology imaging software... Show more
The RSI Oscillator for PMCUF moved out of oversold territory on November 12, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 21 similar instances when the indicator left oversold territory. In of the 21 cases the stock moved higher. This puts the odds of a move higher at .
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 21 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The Moving Average Convergence Divergence (MACD) for PMCUF just turned positive on November 19, 2025. Looking at past instances where PMCUF's MACD turned positive, the stock continued to rise in of 38 cases over the following month. The odds of a continued upward trend are .
PMCUF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on November 19, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on PMCUF as a result. In of 70 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PMCUF declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for PMCUF entered a downward trend on November 28, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. PMCUF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: PMCUF's P/B Ratio (112.360) is slightly higher than the industry average of (21.322). P/E Ratio (249.569) is within average values for comparable stocks, (104.811). PMCUF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.426). Dividend Yield (0.002) settles around the average of (0.028) among similar stocks. P/S Ratio (135.135) is also within normal values, averaging (66.972).
Industry ServicestotheHealthIndustry
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| GLOF | 52.75 | 0.18 | +0.34% |
| iShares Global Equity Factor ETF | |||
| SPTI | 28.93 | 0.01 | +0.05% |
| State Street SPDR Port Itmt Term Trs ETF | |||
| MTUL | 32.83 | N/A | N/A |
| ETRACS 2x Lvrgd MSCI US Mntm Fctr TR ETN | |||
| DXIV | 63.08 | -0.08 | -0.12% |
| Dimensional International Vector Eq ETF | |||
| RLY | 31.65 | -0.12 | -0.39% |
| State Street® Multi-Asset Real Ret ETF | |||
A.I.dvisor tells us that PMCUF and OCLCF have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PMCUF and OCLCF's prices will move in lockstep.
| Ticker / NAME | Correlation To PMCUF | 1D Price Change % | ||
|---|---|---|---|---|
| PMCUF | 100% | N/A | ||
| OCLCF - PMCUF | 32% Poorly correlated | N/A | ||
| TMSNY - PMCUF | 29% Poorly correlated | N/A | ||
| FSLY - PMCUF | 29% Poorly correlated | -0.94% | ||
| NEXXY - PMCUF | 22% Poorly correlated | N/A | ||
| TMNSF - PMCUF | 21% Poorly correlated | N/A | ||
More | ||||
| Ticker / NAME | Correlation To PMCUF | 1D Price Change % |
|---|---|---|
| PMCUF | 100% | N/A |
| Services to the Health Industry industry (91 stocks) | 7% Poorly correlated | +0.20% |
| Health Services industry (421 stocks) | 7% Poorly correlated | +0.70% |